Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debasish Sundi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Biology of Sex Differences|May 13, 2025
Sex differences in bladder cancer: understanding biological and clinical implicationsPrakash Chaudhary, Biplab Singha, Hany A Abdel-Hafiz, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancerJohanna M Schafer, No-Joon Song, Tong Xiao, et al.
The Lancet. Oncology|December 8, 2025
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based studyJacob D Lesinski, Jingbo Yi, Elizabeth Ghias, et al.
The Journal of Clinical Investigation|August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapyHimanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
Nature Immunology|March 28, 2026
ZFP148 is a transcriptional repressor of cytolytic effector CD8<sup>+</sup> T cell differentiationTong Xiao, Xingyu Chen, No-Joon Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Biology of Sex Differences|May 13, 2025
Sex differences in bladder cancer: understanding biological and clinical implicationsPrakash Chaudhary, Biplab Singha, Hany A Abdel-Hafiz, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancerJohanna M Schafer, No-Joon Song, Tong Xiao, et al.
The Lancet. Oncology|December 8, 2025
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based studyJacob D Lesinski, Jingbo Yi, Elizabeth Ghias, et al.
The Journal of Clinical Investigation|August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapyHimanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
Nature Immunology|March 28, 2026
ZFP148 is a transcriptional repressor of cytolytic effector CD8<sup>+</sup> T cell differentiationTong Xiao, Xingyu Chen, No-Joon Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 8